COSMOS Pharmaceutical (3349.T) Earnings Analysis

COSMOS Pharmaceutical (3349.T) next reports earnings on 2026-10-14, consensus EPS 105.98 JPY. Last quarter (2026-07-13) it missed with EPS 117.31 JPY vs 117.37 JPY est (-0.1%). It has beaten estimates in 4/8 recent quarters (50%). Trailing P/E 15.34.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 3349.T next report earnings?

Next earnings date2026-10-14
Consensus EPS estimate105.98 JPY
Revenue estimate295.48B

3349.T earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-07-13117.31 JPY117.37 JPY-0.1%Miss
2026-04-13102.2 JPY100.69 JPY+1.5%Beat
2026-01-1381.73 JPY84.01 JPY-2.7%Miss
2025-10-14103.1 JPY112.02 JPY-8%Miss
2025-07-11108.95 JPY112.38 JPY-3.1%Miss
2025-04-1499.86 JPY76.4 JPY+30.7%Beat
2025-01-1079.31 JPY73.42 JPY+8%Beat
2024-10-11102.74 JPY88.69 JPY+15.8%Beat

Beat rate: 4/8 (50%) over reported quarters with consensus data.

3349.T valuation and analyst view

Trailing P/E15.34
Trailing EPS404.33 JPY
Price / book1.73
Dividend yield1.32%
Market cap489.89B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is COSMOS Pharmaceutical (3349.T)'s next earnings date?

COSMOS Pharmaceutical is next scheduled to report on 2026-10-14, with a consensus EPS estimate of 105.98 JPY and revenue estimate of 295.48B.

Did 3349.T beat earnings last quarter?

In its 2026-07-13 report, 3349.T posted EPS of 117.31 JPY versus a 117.37 JPY estimate — a miss of 0.1%.

What is 3349.T's earnings track record?

Over the last 8 reported quarters with consensus data, 3349.T beat estimates 4 times (50%).

What is 3349.T's current P/E ratio and EPS?

3349.T trades at a trailing P/E of 15.34 on trailing EPS of 404.3302168893599 JPY.

What do analysts rate 3349.T?

3349.T has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.